beta 2-Microglobulin

• 

  Subject Areas on Research

  • A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition. 
  • A placebo-controlled trial of ranitidine in patients with early human immunodeficiency virus infection. 
  • Amelioration of proximal renal tubular dysfunction in type I glycogen storage disease with dietary therapy. 
  • Amphiphilic α-helical potential: a putative folding motif adding few constraints to protein evolution. 
  • Antifibrinolytic agents make alpha1- and beta2-microglobulinuria poor markers of postcardiac surgery renal dysfunction. 
  • Branhamella catarrhalis activates human B lymphocytes following interactions with surface IgD and class I major histocompatibility complex antigens. 
  • Breaking bad blood: β2-microglobulin as a pro-aging factor in blood. 
  • CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo. 
  • Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. 
  • Chemoattractant-induced activation of c-fos gene expression in human monocytes. 
  • Clinical characteristics, response to therapy, and survival of African American patients diagnosed with chronic lymphocytic leukemia: joint experience of the MD Anderson Cancer Center and Duke University Medical Center. 
  • Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/beta -microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells. 
  • Connect MM Registry: The Importance of Establishing Baseline Disease Characteristics. 
  • Contributions of beta2-microglobulin-dependent molecules and lymphocytes to iron regulation: insights from HfeRag1(-/-) and beta2mRag1(-/-) double knock-out mice. 
  • Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. Department of Veterans Affairs Cooperative Study Group. 
  • Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients. 
  • Effect of human immunodeficiency virus infection on serum beta2-microglobulin levels in pregnant women. 
  • Expression of the DMT1 (NRAMP2/DCT1) iron transporter in mice with genetic iron overload disorders. 
  • Genes that modify the hemochromatosis phenotype in mice. 
  • Histologic distribution and biochemical properties of alpha 1-microglobulin in human placenta. 
  • Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. 
  • Increased beta 2-microglobulin (B2M) is useful in the detection of post-transplant lymphoproliferative disease (PTLD). 
  • Induced proteins in human peripheral mononuclear cells over a range of clinically tolerable doses of interferon-gamma. 
  • Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party. 
  • Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance the urinary excretion rate of beta2-microglobulin. 
  • Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and beta(2)-microglobulin in patients with congestive heart failure. 
  • Mannitol and dopamine in patients undergoing cardiopulmonary bypass: a randomized clinical trial. 
  • Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. 
  • Prognostic value of combined response markers among human immunodeficiency virus-infected persons: possible aid in the decision to change zidovudine monotherapy. 
  • Purification and characterization of papain-solubilized HLA antigens from human platelets. 
  • Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS. 
  • Sensitivity and specificity of a monitoring test. 
  • Structural analysis of the functional sites of class I HLA antigens. 
  • Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice. 
  • Tubular markers in renal transplant patients under cyclosporine. 
  • Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases. 
  • Two distinct forms of soluble MHC class I molecules synthesized by different mechanisms in normal rat cells in vitro.